Transcriptional regulation of plasminogen activator inhibitor-1 expression in human synovial fibroblasts by prostaglandin E2: mediation by protein kinase A and role of interleukin-1

Molecular and Cellular Endocrinology
J A DiBattistaJ P Pelletier

Abstract

Differential expression of PAI-1 in connective tissues has been associated etiologically with some forms of arthritis. Our objective was to delineate the mechanisms by which PGE2 and IL-1 beta, inflammatory mediators commonly found at sites of inflammation, regulate the expression and synthesis of PAI-1 in human synoviocytes. PGE2 (and PGE1) inhibited PAI-1 mRNA expression and secretion in a dose-dependent manner with an IC50 (for antigen secretion) of 4.6 x 10(-10) M and 8.7 x 10(-10) M, respectively. Cyclic AMP agonists forskolin, Sp-cAMP, and IBMX mimic the effects of the PGEs. rhIL-1 beta stimulated the secretion of PAI-1 in a dose-dependent fashion under basal culture conditions; the effect was reversed by actinomycin D and the protein kinase inhibitors H7 and staurosporine but not KT-5720. PMA, an activator of protein kinase C, transiently increased (maximum 3 h) the expression of PAI-1 mRNA by approximately 10-fold, especially the 3.2 kb species. However, there was no significant increase in PAI-1 antigen secreted into the culture medium after PMA (100-300 nM) treatment. The half-life (t1/2) of PAI-1 mRNA, both the 3.2 and 2.2 transcripts was about 9.6 h (mean n = 3) and PGE2 has no affect on the stability of both messag...Continue Reading

References

Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·D S NewcombeJ V Fahey
Jan 1, 1978·Annual Review of Biochemistry·B SamuelssonC Malmsten
Dec 4, 1992·Annals of the New York Academy of Sciences·J A HamiltonD Cheung
Aug 1, 1992·Annals of the Rheumatic Diseases·E J BrommerF C Breedveld
Nov 1, 1991·Trends in Genetics : TIG·R Schüle, R M Evans
Feb 1, 1991·The Journal of Clinical Endocrinology and Metabolism·J A DiBattistaJ P Pelletier
Jan 2, 1990·Molecular and Cellular Endocrinology·P A AndreasenS N Stacey
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·W W LamphI M Verma
May 3, 1990·The New England Journal of Medicine·E D Harris
Jan 1, 1989·Arthritis and Rheumatism·S B Abramson, G Weissmann
Apr 1, 1987·The Journal of Cell Biology·F BlasiK Danø
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T NyD J Loskutoff
Jun 1, 1993·Molecular and Cellular Endocrinology·M D Mitchell, M S Trautman
Jan 14, 1993·The New England Journal of Medicine·C A Dinarello, S M Wolff
Mar 5, 2003·The Journal of Biological Chemistry·Cheng-Gang Zou, Ruma Banerjee

❮ Previous
Next ❯

Citations

Sep 30, 2014·Prostaglandins & Other Lipid Mediators·Kamal M KassemPamela Harding
Oct 11, 2011·PloS One·Steven J Coultrap, K Ulrich Bayer
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael H PillingerSteven B Abramson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.